TriMas (NASDAQ:TRS) Downgraded by StockNews.com to “Sell”

StockNews.com downgraded shares of TriMas (NASDAQ:TRSFree Report) from a hold rating to a sell rating in a research report sent to investors on Tuesday morning.

Separately, BWS Financial reissued a “buy” rating and issued a $40.00 price target on shares of TriMas in a report on Tuesday.

View Our Latest Research Report on TRS

TriMas Stock Down 0.3 %

TRS opened at $27.32 on Tuesday. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.83 and a quick ratio of 1.48. The business has a 50 day simple moving average of $25.99 and a 200-day simple moving average of $25.85. The stock has a market capitalization of $1.11 billion, a P/E ratio of 42.69 and a beta of 0.66. TriMas has a 12 month low of $22.45 and a 12 month high of $28.51.

TriMas (NASDAQ:TRSGet Free Report) last issued its quarterly earnings data on Monday, November 4th. The industrial products company reported $0.43 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.57 by ($0.14). The firm had revenue of $229.36 million for the quarter, compared to analyst estimates of $239.33 million. TriMas had a return on equity of 9.21% and a net margin of 2.93%. The business’s revenue for the quarter was down 2.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.57 earnings per share. On average, equities analysts anticipate that TriMas will post 1.75 earnings per share for the current fiscal year.

TriMas Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 12th. Stockholders of record on Tuesday, November 5th will be given a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.59%. The ex-dividend date of this dividend is Tuesday, November 5th. TriMas’s dividend payout ratio is currently 25.00%.

Institutional Investors Weigh In On TriMas

A number of institutional investors have recently added to or reduced their stakes in the company. Innealta Capital LLC acquired a new position in shares of TriMas during the second quarter worth about $26,000. Quantbot Technologies LP lifted its stake in shares of TriMas by 5.7% during the first quarter. Quantbot Technologies LP now owns 8,933 shares of the industrial products company’s stock worth $239,000 after purchasing an additional 478 shares in the last quarter. Aristides Capital LLC acquired a new position in shares of TriMas during the second quarter worth about $245,000. Algert Global LLC lifted its stake in shares of TriMas by 4.2% during the second quarter. Algert Global LLC now owns 15,779 shares of the industrial products company’s stock worth $403,000 after purchasing an additional 639 shares in the last quarter. Finally, Inspire Investing LLC lifted its stake in shares of TriMas by 17.4% in the third quarter. Inspire Investing LLC now owns 16,155 shares of the industrial products company’s stock worth $412,000 after acquiring an additional 2,389 shares in the last quarter. Hedge funds and other institutional investors own 99.42% of the company’s stock.

TriMas Company Profile

(Get Free Report)

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.

Further Reading

Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.